Leadership Overview
GenScript has 7 executives leading key functions including finance, executive leadership, and group presidencies.
Driven by innovation, GenScript provides comprehensive life science services and products, fostering global research advancements through its integrated platforms and commitment to scientific progress.
Driven by innovation, GenScript provides comprehensive life science services and products, fostering global research advancements through its integrated platforms and commitment to scientific progress.
Leadership Roles at GenScript
Patrick Liu - Acting Chief Executive Officer, ProBio
Patrick Liu, the Acting Chief Executive Officer, ProBio at GenScript, spearheads the strategic direction and operational execution for the ProBio division. This critical role involves driving innovation and market penetration within the biologics contract development and manufacturing organization (CDMO) platform. Liu focuses on enhancing service offerings, optimizing production capabilities, and ensuring client satisfaction for global research communities. His leadership ensures the ProBio platform effectively supports the development and manufacturing of complex biologics, aligning with GenScript's overarching goal of providing one-stop solutions. By fostering cross-functional collaboration and implementing advanced operational strategies, Patrick Liu strengthens GenScript's position as a leading biotech company.
Phil Zhou - Chief Financial Officer
Phil Zhou, the Chief Financial Officer at GenScript, directs all financial operations and strategic fiscal planning. Overseeing capital allocation and investment strategies, Zhou ensures robust financial health across the company's diverse platforms, including life-science services, biologics CDMO, industrial synthetic products, and the integrated global cell therapy platform. This leadership role involves managing budgets, optimizing resource deployment, and driving profitability to support GenScript's mission of advancing global research. By maintaining stringent financial controls and identifying growth opportunities, Phil Zhou directly contributes to the company's expansion and market leadership in the biotech sector. His oversight extends to financial reporting, compliance, and investor relations, solidifying GenScript's position as a trusted partner in the life sciences.
Luquan Wang - Executive Director and President
Luquan Wang, the Executive Director and President at GenScript, provides overarching leadership and strategic guidance across key organizational functions. This executive position involves directing major initiatives and ensuring alignment with GenScript's core mission of delivering premier life science services and products globally. Wang's responsibilities encompass fostering innovation, driving operational excellence, and cultivating strategic partnerships to expand the company's market reach. By overseeing critical business segments and championing the company's growth objectives, Luquan Wang plays a pivotal part in maintaining GenScript's status as a world-leading biotech entity. His executive oversight ensures the seamless integration of GenScript's diverse platforms.
Patrick L. - President, Biosciences Group
Patrick L., the President, Biosciences Group at GenScript, directs the strategic vision and operational management of the company's biosciences division. This leadership role focuses on advancing GenScript's life-science services and products platform, ensuring it provides comprehensive, one-stop solutions to global research communities. Patrick L. oversees the development and delivery of cutting-edge research tools and services, driving scientific discovery and innovation. His mandate includes expanding market share, enhancing customer engagement, and fostering a culture of scientific excellence within the group. By optimizing resource allocation and spearheading new product initiatives, Patrick L. significantly contributes to GenScript's mission of empowering scientific progress worldwide.
Janice Jin - Division President, , Life Science Group, Genscript (APAC)
Janice Jin, the Division President, Life Science Group, Genscript (APAC) at GenScript, leads the strategic development and operational execution for the Life Science Group across the Asia-Pacific region. This pivotal role involves expanding GenScript's footprint and service offerings within this key market, ensuring seamless delivery of life science services and products to regional research communities. Jin focuses on driving growth, enhancing customer relationships, and adapting global strategies to meet local market demands. Her leadership ensures the APAC region effectively contributes to GenScript's mission of empowering scientific advancement. By overseeing regional operations and fostering local partnerships, Janice Jin strengthens GenScript's global presence and impact.
Sally Wang - President
Sally Wang, the President at GenScript, provides executive leadership and strategic direction across multiple facets of the organization. This broad role encompasses overseeing key business units and driving initiatives that align with GenScript's mission to deliver world-class life science services and products. Wang focuses on enhancing operational efficiency, fostering innovation, and expanding the company's global reach. Her leadership ensures that GenScript's diverse platforms, including its CDMO and cell therapy capabilities, operate cohesively to meet the evolving needs of the global research community. By championing strategic growth and operational excellence, Sally Wang reinforces GenScript's position as a leader in the biotech industry.
Ray Chen - President, Life Science Group
Ray Chen, the President, Life Science Group at GenScript, directs the strategic growth and operational performance of the company's Life Science Group. This leadership position involves overseeing the development and delivery of a comprehensive suite of life science services and products designed to support global research communities. Chen focuses on driving innovation, enhancing service quality, and expanding market penetration to solidify GenScript's position as a leading biotech provider. His responsibilities include fostering collaboration across departments, optimizing resource allocation, and ensuring the group's offerings meet the highest standards of scientific rigor and customer satisfaction. Through strategic oversight, Ray Chen significantly contributes to GenScript's mission of empowering scientific discovery.
Explore Leadership Teams in Business Services
Riverside Research operates as a not-for-profit scientific research organization dedicated to advancing technological innovation and solving complex challenges for government agencies and the broader public interest. The organization maintains a commitment to conducting rigorous, mission-critical research that addresses national priorities and contributes to scientific advancement across multiple disciplines. The organization has developed substantial expertise in applied research, systems analysis, and technical problem-solving. Riverside Research brings together multidisciplinary teams of scientists, engineers, and researchers who collaborate on projects spanning defense technology, information systems, advanced analytics, and strategic research initiatives. This collaborative approach enables the organization to tackle sophisticated technical challenges that require integration of multiple scientific and engineering domains. Riverside Research delivers comprehensive research and development services that translate scientific discovery into practical solutions. The organization's work encompasses fundamental research, applied development, testing and evaluation, and technical consulting. By maintaining independence as a not-for-profit entity, Riverside Research operates with flexibility to pursue research directions aligned with national needs while maintaining objectivity and scientific rigor in its investigations and analyses.
Company Leadership
EF
TF
KC
The Urban Institute operates as a nonpartisan research organization committed to generating rigorous analysis and evidence-based insights on critical social and economic policy questions. Through empirical research and data-driven investigation, the organization works to inform public discourse and guide policymakers toward solutions that address complex societal challenges. The institute's work spans multiple dimensions of policy analysis, examining issues that directly affect communities and individuals across diverse socioeconomic circumstances. The organization maintains a multidisciplinary approach to research, bringing together economists, social scientists, and policy experts who collaborate to produce comprehensive studies and evaluations. This collaborative model enables the institute to examine interconnected policy challenges from multiple perspectives, generating nuanced findings that reflect the complexity of real-world problems. The research teams conduct original data collection, statistical analysis, and longitudinal studies designed to track outcomes and measure the effectiveness of various policy interventions. Urban Institute research addresses a broad spectrum of policy domains, including economic opportunity, education systems, health care access, housing markets, and government effectiveness.
Company Leadership
YK
Beam Therapeutics is a biotechnology company developing precision genetic medicines using base editing. The company advances research and clinical programs aimed at providing durable treatments for serious diseases, supported by scientific leadership and drug development capabilities. Beam focuses on translating genome editing science into potential lifelong therapies for patients.
Company Leadership JE
GC
CB
Genewiz is an R&D genomics services company providing Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next-generation sequencing, bioinformatics, and GLP regulatory services. The company was founded in 1999 and is headquartered in South Plainfield, New Jersey.
Company Leadership
SV
JD
LL
Frequently Asked Questions Regarding GenScript Top Executives and Leadership Team
